EMEA-000145-PIP02-12-M04
Key facts
| Invented name |
|
| Active substance |
denosumab
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/0213/2021
|
| PIP number |
EMEA-000145-PIP02-12-M04
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of osteoporosis
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Amgen Europe B.V.
E-mail: medinfointernational@amgen.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|